Consolidated Statements of Financial Position | Financial Information | Investor Relations

Consolidated Statements of Financial Position (Consolidated Balance Sheets)　Full Year （35KB）

（Millions of Yen）

	2018/3	2019/3	2020/3	2021/3~{1,2}	2022/3	2023/3	2024/3	2025/3
Asset
Cash and Cash Equivalents	868,325	546,784	880,100	1,065,726	1,127,523	1,651,851	1,420,430	1,043,944
Call Loans for Banking Business	78,000	20,000	-	65,000	80,000	98,000	116,082	63,000
Trade and Other Receivables	297,050	328,281	386,799	480,195	368,618	623,300	684,011	673,275
Inventories	17,685	18,306	20,889	24,668	26,671	31,690	35,028	32,436
Loans for Credit Card Business	186,711	253,340	342,245	407,955	475,528	593,058	783,869	983,790
Investment Securities for Banking Business	308,436	419,551	415,809	517,984	464,145	414,719	655,075	908,887
Loans for Banking Business	76,077	80,942	98,752	247,047	414,620	620,383	723,167	926,334
Other Financial Assets	163,380	191,260	264,213	448,210	511,487	447,841	456,812	398,510
Property and Equipment	123,943	133,867	131,215	150,478	164,783	213,839	238,399	262,172
Right-of-use Assets	-	-	106,304	150,928	162,763	221,221	189,292	178,673
Goodwill	162,015	175,301	400,034	1,790,487	1,788,481	2,074,779	2,067,862	2,073,470
Intangible Assets	167,112	165,293	679,375	1,061,780	1,216,379	1,267,738	1,248,923	1,233,421
Investments Accounted for Using the Equity Method	10,865	24,510	8,567	177,650	203,398	191,048	240,342	265,599
Deferred Tax Assets	27,686	34,551	43,739	39,427	37,176	44,477	29,030	44,238
Other Assets	14,373	37,609	155,863	63,788	68,806	94,772	155,640	70,592
Subtotal	2,501,662	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346
Assets classified as held-for-sale	14,970	-	-	-	-	-	-	-
Total Assets	2,516,633	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346

（Millions of Yen）

	2018/3	2019/3	2020/3	2021/3~{1,2}	2022/3	2023/3	2024/3	2025/3
Liabilities
Trade and Other Payables	348,346	394,545	589,342	616,681	524,989	1,351,794	1,551,611	1,712,145
Deposits for Banking Business	708,054	768,613	903,118	1,186,206	1,431,175	1,495,629	1,672,746	1,830,293
Interest-bearing Liabilities	190,574	215,212	1,086,436	1,389,563	1,666,503	1,913,799	1,882,752	1,694,398
Other Financial Liabilities	5,034	8,683	10,157	10,759	8,528	14,729	27,054	26,610
Income Taxes Payable	29,094	24,138	32,887	47,024	43,186	31,616	38,361	50,060
Provisions	30,652	30,360	28,161	33,075	28,619	23,136	25,630	29,544
Deferred Tax Liabilities	22,956	20,403	160,976	278,216	262,539	240,772	190,614	188,084
Other Liabilities	56,818	57,118	75,006	140,203	162,645	199,345	208,211	208,293
Subtotal	1,391,532	1,519,077	2,886,086	3,701,730	4,128,188	5,270,822	5,596,983	5,739,431
Liabilities directly associated with assets classified as held for sale	3,214	-	-	-	-	-	-	-
Total Liabilities	1,394,746	1,519,077	2,886,086	3,701,730	4,128,188	5,270,822	5,596,983	5,739,431

Equity
Equity Attributable to Owners of the Parent
Common Stock	8,737	8,939	237,422	237,724	237,980	247,094	248,144	250,128
Capital Surplus	(4,602)	(12,545)	212,539	2,063,881	2,037,384	2,046,696	2,060,766	1,880,031
Retained Earnings	993,894	832,147	330,752	362,999	401,322	647,347	723,884	838,017
Treasury Stock	(1,316)	(24,440)	(17,382)	(17,385)	(54,086)	(70,436)	(70,037)	(11,704)
Accumulated Other Comprehensive Income	16,655	14,190	8,216	35,098	61,776	48,697	74,329	41,696
Total Equity Attributable to Owners of the Parent	1,013,368	818,291	771,548	2,682,318	2,684,377	2,919,399	3,037,088	2,998,170
Non-controlling Interests	108,518	92,231	276,274	307,279	297,819	398,501	409,897	420,745
Total Equity	1,121,887	910,523	1,047,823	2,989,597	2,982,197	3,317,900	3,446,985	3,418,915
Total Liabilities and Equity	2,516,633	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346

Notes

The consolidated financial statements of the fiscal year ended March 31, 2021 have been retroactively revised with the finalization of the provisional accounting made in the consolidated second quarter of the fiscal year ending March 31, 2022 in connection with the business combination.
In FY2021-Q3, recorded impairment loss on investments in associates and joint ventures of ¥18.3 billion due to the reduction of the carrying amount of the investment accounted for using the equity method with regard to Demae-can Co., Ltd., to the recoverable amount.